Daxor Corporation Announces Sale Of BVA-100 Blood Volume Analyzer To Nebraska Medicine
NEW YORK, NY--(Marketwired - Feb 8, 2016) - Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, announced today that Nebraska Medicine has purchased a BVA-100 Blood Volume Analyzer.
Nebraska Medicine offers exceptional patient care combined with innovative research and education. Committed to advancing quality health care, Nebraska Medicine represents the clinical integration of The Nebraska Medical Center; the state's largest and highest rated hospital, Bellevue Medical Center and UNMC Physicians. Their newly integrated organization allows them to strengthen their services by expanding collaboration with their partners and providing patients with access to more than 1,000 physicians and 676 licensed hospital beds as well as approximately 40 specialty and primary care clinics in Omaha and the surrounding area.
Nebraska Medical Center is a 621 acute-care bed facility that provides care to some of the sickest and most complex patients from a team of experts that represents more than 1,000 physicians in all major specialties and subspecialties.
U.S. News & World Report has named Nebraska Medicine the #1 hospital in the state for several years in a row. Becker's Hospital Review has named Nebraska Medicine as one of the 100 Best Hospitals in America for two straight years. According to Newsweek's list of "Top Cancer Doctors 2015," 75 percent of the top cancer doctors in the state are at Nebraska Medicine. Nebraska Medical Center has an international reputation for providing solid organ and bone marrow transplantation services. Nebraska Medicine, along with its academic partner UNMC, are building the Fred & Pamela Buffett Cancer Center which is the largest project in campus history and scheduled to open in early 2017.
Dr. Joseph Feldschuh, the President and CEO of Daxor, is a cardiologist. Dr. Feldschuh noted that, "We look forward to partnering with Nebraska Medical Center as it continues to offer best in class care that will now integrate blood volume analysis technology, providing its physicians with accurate, actionable information to inform treatment strategies."
Daxor Corporation manufactures and markets the BVA-100 Blood Volume Analyzer, which is used in conjunction with Volumex, Daxor's single use diagnostic kit. For more information regarding Daxor Corporation's Blood Volume Analyzer BVA-100, visit Daxor's website at www.Daxor.com.
Nebraska Medicine offers exceptional patient care combined with innovative research and education. Committed to advancing quality health care, Nebraska Medicine represents the clinical integration of The Nebraska Medical Center; the state's largest and highest rated hospital, Bellevue Medical Center and UNMC Physicians. Their newly integrated organization allows them to strengthen their services by expanding collaboration with their partners and providing patients with access to more than 1,000 physicians and 676 licensed hospital beds as well as approximately 40 specialty and primary care clinics in Omaha and the surrounding area.
Nebraska Medical Center is a 621 acute-care bed facility that provides care to some of the sickest and most complex patients from a team of experts that represents more than 1,000 physicians in all major specialties and subspecialties.
U.S. News & World Report has named Nebraska Medicine the #1 hospital in the state for several years in a row. Becker's Hospital Review has named Nebraska Medicine as one of the 100 Best Hospitals in America for two straight years. According to Newsweek's list of "Top Cancer Doctors 2015," 75 percent of the top cancer doctors in the state are at Nebraska Medicine. Nebraska Medical Center has an international reputation for providing solid organ and bone marrow transplantation services. Nebraska Medicine, along with its academic partner UNMC, are building the Fred & Pamela Buffett Cancer Center which is the largest project in campus history and scheduled to open in early 2017.
Dr. Joseph Feldschuh, the President and CEO of Daxor, is a cardiologist. Dr. Feldschuh noted that, "We look forward to partnering with Nebraska Medical Center as it continues to offer best in class care that will now integrate blood volume analysis technology, providing its physicians with accurate, actionable information to inform treatment strategies."
Daxor Corporation manufactures and markets the BVA-100 Blood Volume Analyzer, which is used in conjunction with Volumex, Daxor's single use diagnostic kit. For more information regarding Daxor Corporation's Blood Volume Analyzer BVA-100, visit Daxor's website at www.Daxor.com.